Micelle-Based Ocular Inserts for Sustained Delivery and Improved Corneal Permeation of Rebamipide in Dry Eye Disease

15. May 2026

Abstract Background: Rebamipide (REB) is a poorly water-soluble drug with limited ocular bioavailability, necessitating advanced delivery strategies for sustained therapy in...

Formulation and Characterization of TPGS-Coated Cabazitaxel Liposomes: In-Vitro Cytotoxicity, Drug Release, and In-Silico Metabolic Modulation

11. May 2026

Abstract Purpose Cabazitaxel (CBZ) is a semi-synthetic anti-cancer drug and belongs to BCS class IV category with poor water solubility...

Effect of drug solubility, polymer, and filler on drug release from modified-release matrix tablets in hydroethanolic media

10. May 2026

Abstract This study aimed to develop strategies to prevent accelerated drug release (alcohol-induced dose dumping) from modified-release matrix tablets in...

The uniform white appearance of the prepared Rebamipide-loaded deep eutectic mixture (DEM) granules.

In Silico Preformulation Modeling, Solubility Enhancement, and Sustainable Release of Rebamipide Utilizing Deep Eutectic Mixture Loaded Bioadhesive Controlled Release Granules for Gastritis Treatment

6. May 2026

Abstract Background/Objectives: Rebamipide is a gastroprotective agent with poor aqueous solubility and rapid gastrointestinal clearance, leading to reduced therapeutic efficiency. This...

Sodium Stearate-Assisted Optimization of a Cannabidiol Dry Powder Inhaler for Enhanced Dissolution and Aerosol Performance

3. May 2026

Abstract Background/Objectives: Cannabidiol (CBD) has emerged as a potential therapeutic agent for respiratory disorders, including asthma and chronic obstructive pulmonary...

Webinar: Nano-Formulations: Turning Insoluble APIs into Effective Dosage Forms

20. April 2026

See our next Live Webinar on the topic of: Nano-Formulations: Turning Insoluble APIs into Effective Dosage Forms Presentation 1:...

Development of amorphous solid dispersion of delamanid, an extremely water-insoluble drug, by hot melt extrusion applying acid-base supersolubilization (ABS) principle

3. April 2026

Abstract Delamanid, an antituberculosis drug used for multidrug-resistant tuberculosis, has extremely poor water solubility and a high melting point of...

Towards Rational Excipient Selection: Assessing Lactose-Based Co-Processed Excipients with APIs of Differing Solubilities

29. March 2026

Abstract Purpose This research was designed to systematically investigate the performance of three lactose-based co-processed excipients (CPEs): SuperTab® 40LL, StarLac®, and...

Enhanced Solubility of High Melting BCS Class IV Compounds Using Novel Liquid-Assisted Hot Melt Extrusion

29. March 2026

Abstract Insufficient aqueous dissolution properties constitute a fundamental barrier impacting approximately 40% of commercialized and 90% developmental pharmaceuticals, significantly limiting...

Fluidized bed granulation of a poorly soluble API with phospholipids to increase solubility

27. March 2026

This poster has been presented at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology which took place in...

Solubility Enhancement